BRTXNasdaq United States
Market cap
$5.198 M
$0.20 -2.11%
Close of 7 Aug 2026
Revenue
$359.7K
#3570 by revenue
Earnings
-$14.2M
Loss-making
Shares outstanding
25,478,170
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Where these numbers come from
Share counts and financials for BioRestorative Therapies are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.